Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Dev Growth Differ ; 61(7-8): 419-430, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31468519

ABSTRACT

Zebrafish have the ability to regenerate skeletal structures, including the fin, skull roof, and jaw. Although fin regeneration proceeds by epimorphic regeneration, it remains unclear whether this process is involved in other skeletal regeneration in zebrafish. Initially in epimorphic regeneration, the wound epidermis covers the wound surface. Subsequently, the blastema, an undifferentiated mesenchymal mass, forms beneath the epidermis. In the present study, we re-examined the regeneration of the zebrafish lower jaw in detail, and investigated whether epimorphic regeneration is involved in this process. We performed amputation of the lower jaw at two different positions; the proximal level (presence of Meckel's cartilage) and the distal level (absence of Meckel's cartilage). In both manipulations, a blastema-like cellular mass was initially formed. Subsequently, cartilaginous aggregates were formed in this mass. In the proximal amputation, the cartilaginous aggregates were then fused with Meckel's cartilage and remained as a skeletal component of the regenerated jaw, whereas in the distal amputation, the cartilaginous aggregates disappeared as regeneration progressed. Two molecules that were observed during epimorphic regeneration, Laminin and msxb, were expressed in the regenerating lower jaw, although the domain of msxb expression was out of the main plain of the aggregate formation. Administration of an inhibitor of Wnt/ß-catenin signaling, a pathway associated with epimorphic regeneration, showed few effects on lower jaw regeneration. Our finding suggests that skeletal regeneration of the lower jaw mainly progresses through tissue regeneration that is dependent on the position in the jaw, and epimorphic regeneration plays an adjunctive role in this regeneration.


Subject(s)
Epidermis/physiology , Extremities/physiology , Jaw/physiology , Regeneration/physiology , Wound Healing/physiology , Zebrafish/physiology , Amputation, Surgical , Animals , Cartilage/metabolism , Cartilage/physiology , Cartilage/surgery , Homeodomain Proteins/metabolism , Jaw/metabolism , Laminin/metabolism , Wnt Signaling Pathway/physiology , Zebrafish Proteins/metabolism
2.
Neurol Res ; 41(9): 811-816, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31064275

ABSTRACT

Background: Intracranial vertebral artery dissection (VAD) and moyamoya disease (MMD) are rare cerebrovascular diseases, both of which have an ethnic predominance in the East Asian population. Disruption of the internal elastic lamina and subsequent rupture of the medial layer result in intracranial VAD. MMD is a chronic occlusive cerebrovascular disease of unknown etiology, in which the medial layer and internal elastic lamina of the intracranial arteries are significantly compromised. Recent genetic studies found ring finger protein 213 (RNF213) to be an important susceptibility gene for MMD in East Asian patients, but the association between VAD and RNF213 has not been investigated. . Methods: We investigated polymorphism of the RNF213 gene (c.14576G>A) in genomic DNA of 24 patients with intracranial VAD in comparison with 58 patients with definitive MMD and 48 healthy controls. Results: Although RNF213 gene polymorphism (c.14576G>A) was evident in 69% of the MMD patients (40/58), none of the patients with intracranial VAD had this characteristic polymorphism (0/24, p < 0.001). The incidence of RNF213 c.14576G>A polymorphism was 4.2% in healthy controls (2/48). After adjustment by age and sex, the incidence of RNF213 c.14576G>A was significantly lower in intracranial VAD patients (p = 0.021) than that in MMD patients. Conclusions: In contrast to MMD patients, the prevalence of RNF213 c.14576G>A polymorphism was significantly lower in patients with intracranial VAD. The RNF213 gene polymorphism may preferentially affect the cerebrovascular lesion in the anterior circulation, which is originated from the primitive internal carotid arteries. The genetic background underlying intracranial VAD should be elucidated in future studies. Abbreviations: VAD: vertebral artery dissection; MMD: moyamoya disease; RNF213: ring finger protein 213; CAD: carotid artery dissection.


Subject(s)
Adenosine Triphosphatases/genetics , Genetic Predisposition to Disease/genetics , Moyamoya Disease/genetics , Polymorphism, Single Nucleotide/physiology , Ubiquitin-Protein Ligases/genetics , Asian People/genetics , Female , Genotype , Humans , Male , Vertebral Artery Dissection/genetics
3.
Brain Res ; 1699: 54-68, 2018 11 15.
Article in English | MEDLINE | ID: mdl-29981290

ABSTRACT

Cerebral venous thrombosis (CVT) is a rare form of cerebral stroke that causes a variety of symptoms, ranging from mild headache to severe morbidity or death in the more severe forms. The use of anti-coagulant or thrombolytic agents is the classical treatment for CVT. However, the development of new therapies for the treatment of the condition has not been the focus. In this study, we aimed to analyze the pathophysiology of CVT and to identify the pathways associated with its pathology. Moreover, mechanisms that are potential drug targets were identified. Our data showed the intense activation of immune cells, particularly the microglia, along with the increase in macrophage activity and NLRP3 inflammasome activation that is indicated by NLRP3, IL-1ß, and IL-18 gene and caspase-1 upregulation and cleavage as well as pyroptotic cell death. Leukocytes were observed in the brain parenchyma, indicating a role in CVT-induced inflammation. In addition, astrocytes were activated, and they induced glial scar leading to parenchymal contraction during the subacute stage and tissue loss. MMP9 was responsible primarily for the BBB breakdown after CVT and it is mainly produced by pericytes. MMP9 activation was observed before inflammatory changes, indicating that BBB breakdown is the initial driver of the pathology of CVT. These results show an inflammation driven pathophysiology of CVT that follows MMP9-mediated BBB breakdown, and identified several targets that can be targeted by pharmaceutical agents to improve the neuroinflammation that follows CVT, such as MMP9, NLRP3, and IL-1ß. Some of these pharmaceutical agents are already in clinical practice or under clinical trials indicating a good potential for translating this work into patient care.


Subject(s)
Blood-Brain Barrier/metabolism , Cerebrovascular Disorders/metabolism , Inflammasomes/metabolism , Pyroptosis/physiology , Superior Sagittal Sinus/metabolism , Venous Thrombosis/metabolism , Animals , Blood-Brain Barrier/pathology , Cerebrovascular Disorders/pathology , Disease Models, Animal , Inflammation/metabolism , Inflammation/pathology , Male , Rats, Sprague-Dawley , Superior Sagittal Sinus/pathology , Venous Thrombosis/pathology
4.
Neuroscience ; 384: 188-202, 2018 08 01.
Article in English | MEDLINE | ID: mdl-29782904

ABSTRACT

Sphingosine-1-phosphate (S1P) is a sphingolipid molecule produced by the action of sphingosine kinases (SphK) on sphingosine. It possesses various intracellular functions through its interactions with intracellular proteins or via its action on five G-protein-coupled cell membrane receptors. Following transient global cerebral ischemia (tGCI), only the CA1 subregion of the hippocampus undergoes apoptosis. In this study, we evaluated S1P levels and S1P-processing enzyme expression in different hippocampal areas following tGCI in rats. We found that S1P was upregulated earlier in CA3 than in CA1. This was associated with upregulation of SphK1 in both regions; however, SphK2 was downregulated quickly in CA3. S1P lyase was also downregulated in CA3, but not in CA1. Spinster 2, the S1P exporter, was upregulated early in both regions, but was quickly downregulated in CA3. Together, these effects explain the variable levels of S1P in the CA1 and CA3 areas and indicate that S1P levels play a role in the preferential resistance of the CA3 subregion to tGCI-induced ischemia. FTY720 did not improve neuronal survival in the CA1 subregion, indicating that these effects were due to intracellular S1P accumulation. In conclusion, the findings suggest that intracellular S1P levels affect neuronal cell fate following tGCI.


Subject(s)
Hippocampus/metabolism , Ischemic Attack, Transient/metabolism , Lysophospholipids/metabolism , Neurons/metabolism , Sphingosine/analogs & derivatives , Animals , Apoptosis/physiology , Down-Regulation , Hippocampus/pathology , Ischemic Attack, Transient/pathology , Male , PC12 Cells , Rats , Rats, Sprague-Dawley , Sphingosine/metabolism , Up-Regulation
5.
Brain Res ; 1679: 39-44, 2018 01 15.
Article in English | MEDLINE | ID: mdl-29174692

ABSTRACT

Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by a progressive stenosis at the terminal portion of the internal carotid artery and an abnormal vascular network at the base of the brain. Although its etiology is still unknown, intrinsic immune reactions such as autoimmune response has been implicated in the pathogenesis of MMD. Recently, the RING finger protein 213 (RNF213) was found to be an important risk gene for MMD, and is predominantly expressed in blood cells and the spleen. Thus, we hypothesized that patients with MMD represent an intrinsic autoimmune status mediated by M2-polarized macrophages, which play an important role in tissue remodeling and angiogenesis. We compared the serum level of soluble (s)CD163, an activating marker for CD163+ M2-polarized macrophages that has been implicated in a variety of autoimmune disorders, between MMD patients and healthy controls. We also analyzed serum levels of CXCL5, an augmented cytokines that has been correlated with the severity of autoimmune diseases. As a result, the serum sCD163 levels of MMD patients (281,465 pg/ml) were significantly higher than those of healthy controls (174,842 pg/ml) (p = .004). The serum CXCL5 levels of MMD patients (679.02 pg/ml) were significantly higher than those of healthy controls (401.79 pg/ml) (p = .046). There were no differences in the serum sCD163 and CXCL5 levels between each genotype of the RNF213 polymorphism (wild-type or variant) among MMD patients. Although this is a pilot study and further validation with larger number of samples is necessary, our results indicate that patients with MMD may have increased autoimmune activity, and our results shed light on the pathogenesis of MMD via CD163+ M2-polarized macrophages.


Subject(s)
Adenosine Triphosphatases/genetics , Chemokine CXCL5/blood , Cytokine Receptor Common beta Subunit/blood , Gene Expression Regulation/genetics , Moyamoya Disease/blood , Polymorphism, Single Nucleotide/genetics , Ubiquitin-Protein Ligases/genetics , Adult , Amides/pharmacokinetics , Female , Humans , Magnetic Resonance Angiography/methods , Male , Middle Aged , Moyamoya Disease/diagnostic imaging , Moyamoya Disease/genetics , Tomography, Emission-Computed, Single-Photon
6.
J Stroke Cerebrovasc Dis ; 26(9): 1904-1911, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28734662

ABSTRACT

The RING finger protein 213 (RNF213) is an important susceptibility gene for moyamoya disease (MMD) and is also implicated in other types of intracranial major artery stenosis/occlusion (ICAS); however, the role of RNF213 in the development of ICAS including MMD is unclear. The constitutive expression of the RNF213 gene is relatively weak in brain tissue, while information regarding the expression patterns of the RNF213 gene under cerebral ischemia, which is one of characteristic pathologies associated with ICAS, is currently limited. Our objective was to address this critical issue, and we investigated Rnf213 mRNA expression in rat brains after 5 minutes of transient global cerebral ischemia (tGCI) by occluding the common carotid arteries coupled with severe hypotension. Rnf213 gene expression patterns were investigated with in situ RNA hybridization and a real-time polymerase chain reaction (PCR) from 1 to 72 hours after tGCI. In situ RNA hybridization revealed a significant increase in Rnf213 mRNA levels in the hippocampus CA1 sub-region 48 hours after tGCI. The significant induction of the Rnf213 gene was also evident in the ischemic cortex. Double staining of Rnf213 mRNA with NeuN immunohistochemistry revealed Rnf213 hybridization signal expression exclusively in neurons. The real-time PCR analysis confirmed the induction of the Rnf213 gene after tGCI. The up-regulation of the Rnf213 gene in vulnerable neurons in the hippocampus CA1 after tGCI suggests its involvement in forebrain ischemia, which is an underlying pathology of MMD. Further investigations are needed to elucidate its exact role in the pathophysiology of ICAS including MMD.


Subject(s)
Brain Ischemia/metabolism , CA1 Region, Hippocampal/metabolism , Carrier Proteins/metabolism , Moyamoya Disease/metabolism , Neurons/metabolism , Animals , Antigens, Nuclear/metabolism , Brain Ischemia/genetics , Brain Ischemia/pathology , CA1 Region, Hippocampal/pathology , Carrier Proteins/genetics , Disease Models, Animal , Male , Moyamoya Disease/genetics , Nerve Tissue Proteins/metabolism , Neurons/pathology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats, Sprague-Dawley , Time Factors , Up-Regulation
7.
J Stroke Cerebrovasc Dis ; 26(1): e8-e11, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27789153

ABSTRACT

BACKGROUND: The de novo development of moyamoya disease (MMD) in adults is extremely rare, with only 2 cases being previously reported. Furthermore, the mechanisms underlying the progression of adult MMD have not been elucidated yet. CASE REPORT: A transient ischemic attack occurred in a 46-year-old woman, owing to progressive MMD. Magnetic resonance (MR) angiography performed 7 years before the diagnosis of MMD did not detect any steno-occlusive changes in the major intracranial vessels, including the internal carotid artery (ICA) and the middle cerebral artery (MCA). However, during the last 2 years, serial MR angiography revealed the gradual progression of left MCA stenosis and ultimately showed apparent stenosis of the bilateral terminal ICA to proximal MCA. Catheter angiography confirmed the definitive diagnosis of MMD. A genetic analysis of RING-finger protein (RNF)-213, an MMD susceptibility gene, revealed that not only the patient, but also her sister, brother, and daughter had the heterozygous variant of the RNF-213 gene. Because of hemodynamic compromise with ischemic symptoms, the patient underwent revascularization surgery on the affected hemisphere, without complications. She had no cerebrovascular event in the postoperative follow-up period of 8 months, and there was no evidence of the further progression of MMD. CONCLUSION: We herein present the entire clinical course of the de novo development of MMD in a female adult. Newly developed MMD in an adult patient with a characteristic variant of the RNF-213 gene appears to be unique.


Subject(s)
Adenosine Triphosphatases/genetics , Genetic Variation/genetics , Moyamoya Disease/genetics , Ubiquitin-Protein Ligases/genetics , Disease Progression , Female , Humans , Ischemic Attack, Transient/diagnostic imaging , Ischemic Attack, Transient/etiology , Magnetic Resonance Angiography , Magnetic Resonance Imaging , Middle Aged , Moyamoya Disease/complications , Moyamoya Disease/diagnostic imaging
8.
Brain Res ; 1642: 1-9, 2016 07 01.
Article in English | MEDLINE | ID: mdl-26972532

ABSTRACT

Moyamoya disease (MMD) is a chronic, occlusive cerebrovascular disease with an unknown etiology and is characterized by an abnormal vascular network at the base of the brain. Recent studies identified the RNF213 gene (RNF213) as an important susceptibility gene for MMD; however, the mechanisms underlying the RNF213 abnormality related to MMD have not yet been elucidated. We previously reported that Rnf213-deficient mice and Rnf213 p. R4828K knock-in mice did not spontaneously develop MMD, indicating the importance of secondary insults in addition to genetic factors in the pathogenesis of MMD. The most influential secondary insult is considered to be an immunological reaction because RNF213 is predominantly expressed in immunological tissues. Therefore, we herein attempted to evaluate the role of an immunological stimulation as a supplementary insult to the target disruption of RNF213 in the pathophysiology of MMD. Rnf213-deficient mice were treated with strong immunological adjuvants including muramyl dipeptide (MDP)-Lys (L18), and then underwent time-sequential magnetic resonance angiography (MRA) up to 40 weeks of age. The results obtained did not reveal any characteristic finding of MMD, and no significant difference was observed in MRA findings or the anatomy of the circle of Willis between Rnf213-deficient mice and wild-type mice after the administration of MDP-Lys (L18). The ratio of regulatory T cells after the administration of MDP-Lys (L18) was significantly decreased in Rnf213-deficient mice (p<0.01), suggesting the potential role of the RNF213 abnormality in the differentiation of regulatory T cells. Although the mechanisms underlying the development of MMD currently remain unclear, the RNF213 abnormality may compromise immunological self-tolerance, thereby contributing to the development of MMD.


Subject(s)
Adenosine Triphosphatases/genetics , Moyamoya Disease/genetics , Moyamoya Disease/immunology , Moyamoya Disease/pathology , T-Lymphocytes, Regulatory/immunology , Ubiquitin-Protein Ligases/genetics , Adjuvants, Immunologic/administration & dosage , Animals , Cell Count , Circle of Willis/immunology , Circle of Willis/pathology , Female , Genetic Predisposition to Disease , Magnetic Resonance Angiography , Male , Mice , Mice, Inbred C57BL , Self Tolerance , T-Lymphocytes, Regulatory/metabolism
9.
Brain Res ; 1630: 50-5, 2016 Jan 01.
Article in English | MEDLINE | ID: mdl-26556774

ABSTRACT

Although recent genome-wide and locus-specific association studies revealed that the RING finger protein 213 (RNF213) gene is an important susceptibility gene for moyamoya disease (MMD), the exact mechanism by which the genetic alteration of RNF213 contributes to the development of MMD has not yet been elucidated. A quantitative reverse transcription polymerase chain reaction (PCR) analysis revealed that the constitutive expression of the RNF213 gene was very low in adult and embryonic brain tissue. However, information regarding the temporal and spatial expression patterns of the RNF213 gene under the condition of cerebral ischemia, which is one of characteristic pathologies associated with MMD, is currently limited. In order to address this critical issue, Rnf213 mRNA expression was investigated in mouse brains subjected to 60 min of transient middle cerebral artery occlusion (tMCAO). Male C57BL6/j mice underwent tMCAO through the intraluminal blockade of MCA. Expression of the Rnf213 gene in the tMCAO brain was investigated with in situ RNA hybridization and a real-time PCR analysis from 1 to 72 h after tMCAO. In situ RNA hybridization revealed a significant increase in Rnf213 mRNA levels in the cerebral cortex supplied by the affected MCA, especially at the penumbra area, as early as 6h after tMCAO, and these levels had increased further by 24 h. Rnf213 gene expression remained unchanged in the non-ischemic hemisphere or control specimens. Double staining of Rnf213 mRNA with NeuN immunohistochemistry revealed Rnf213 hybridization signal expression mostly in neurons. The real-time PCR analysis confirmed induction of the Rnf213 gene after tMCAO. Therefore, the Rnf213 gene was up-regulated in the ischemic brain, especially at the penumbra area, 6 h after tMCAO. Early increases in RNF213 gene expression in neurons after tMCAO indicate its involvement in cerebral ischemia, which is an underlying pathology of MMD. Further investigation is required to clarify its exact role in the pathophysiology of MMD.


Subject(s)
Brain/metabolism , Infarction, Middle Cerebral Artery/metabolism , Moyamoya Disease/metabolism , Neurons/metabolism , Ubiquitin-Protein Ligases/metabolism , Adenosine Triphosphatases , Animals , Brain/pathology , DNA-Binding Proteins , Disease Models, Animal , Genetic Predisposition to Disease , Immunohistochemistry , In Situ Hybridization , Infarction, Middle Cerebral Artery/pathology , Male , Mice, Inbred C57BL , Moyamoya Disease/genetics , Nerve Tissue Proteins/metabolism , Neurons/pathology , Nuclear Proteins/metabolism , RNA, Messenger , Random Allocation , Real-Time Polymerase Chain Reaction , Ubiquitin-Protein Ligases/genetics
10.
Brain Res ; 1624: 497-505, 2015 Oct 22.
Article in English | MEDLINE | ID: mdl-26315378

ABSTRACT

Moyamoya disease (MMD) is a chronic, occlusive cerebrovascular disease with an unknown etiology. Recent genome-wide and locus-specific association studies identified the RNF213 gene (RNF213) as an important susceptibility gene of MMD among East Asian populations; however, the mechanism by which an abnormality in RNF213 leads to MMD has not yet been elucidated. Therefore, we herein generated Rnf213-knock-in mice (RNF213-KI) expressing a missense mutation in mouse Rnf213, p. R4828K, on Exon 61, corresponding to human RNF213, p. R4859K, on Exon 60, in MMD patients, and investigated whether they developed MMD. We assessed the temporal profile of intracranial arteries by 9.4-T magnetic resonance angiography (MRA) continuously in the same mouse up to 64 weeks of age. The ratios of the outer diameter of the internal carotid artery (ICA)/basilar artery (BA) and middle cerebral artery (MCA)/BA were evaluated histopathologically. The common carotid arteries (CCA) were sectioned and arterial wall thickness/thinness was evaluated by Elastica-Masson staining before and after CCA ligation, which selectively induced vascular hyperplasia. The results obtained showed that RNF213-KI grew normally, with no significant difference being observed in MRA findings or the anatomy of the circle of Willis between homozygous RNF213-KI and wild-type (Wt) littermates. Furthermore, no significant difference was noted in the diameter of the intracranial vasculature (ICA/BA; p=0.82, MCA/BA; p=0.27) or in vascular remodeling after CCA ligation. Therefore, RNF213-KI did not spontaneously develop MMD. Multiple secondary insults such as environmental factors may contribute to the onset of MMD in addition to genetic factors.


Subject(s)
Blood Vessels/pathology , Brain/pathology , Magnetic Resonance Angiography , Moyamoya Disease/pathology , Mutation/genetics , Ubiquitin-Protein Ligases/genetics , Adenosine Triphosphatases , Analysis of Variance , Animals , Arginine/genetics , Disease Models, Animal , Humans , Hyperplasia/etiology , Hyperplasia/pathology , Image Processing, Computer-Assisted , Lysine/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Moyamoya Disease/genetics , Time Factors
11.
Dev Growth Differ ; 50(6): 401-6, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18430027

ABSTRACT

The heat shock promoter is useful for regulating transgene expression in small water-living organisms. In zebrafish embryos, downstream gene expression can be greatly induced throughout the body by raising the temperature from 28.5 degrees C to 38.0 degrees C. By manipulating the local temperature within an embryo, spatial control of transgene expression is also possible. One such way for inducing heat shock response in targeted cells is by using a laser microbeam under the microscope. In addition, random mosaic expression by transient gene expression and transplantation of the transgenic embryo into a wild type host can be considered a powerful tool for studying gene functions using this promoter. In this paper, we review the applications of the zebrafish heat shock protein promoter as a gene expression tool and for lineage labeling and transcription enhancer screening.


Subject(s)
Animals, Genetically Modified , Gene Expression Regulation, Developmental , Heat-Shock Proteins/genetics , Promoter Regions, Genetic , Animals , Base Sequence , Body Temperature , Cell Transplantation/methods , Developmental Biology , HSP70 Heat-Shock Proteins/metabolism , Heat-Shock Proteins/metabolism , Lasers , Molecular Sequence Data , Temperature , Transgenes , Zebrafish
12.
Development ; 135(2): 323-32, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18077593

ABSTRACT

In zebrafish embryos, each myotome is typically innervated by three primary motoneurons (PMNs): the caudal primary (CaP), middle primary (MiP) and rostral primary (RoP). PMN axons first exit the spinal cord through a single exit point located at the midpoint of the overlying somite, which is formed beneath the CaP cell body and is pioneered by the CaP axon. However, the placement of CaP cell bodies with respect to corresponding somites is poorly understood. Here, we determined the early events in CaP cell positioning using neuropilin 1a (nrp1a):gfp transgenic embryos in which CaPs were specifically labeled with GFP. CaP cell bodies first exhibit an irregular pattern in presence of newly formed corresponding somites and then migrate to achieve their proper positions by axonogenesis stages. CaPs are generated in excess compared with the number of somites, and two CaPs often overlap at the same position through this process. Next, we showed that CaP cell bodies remain in the initial irregular positions after knockdown of Neuropilin1a, a component of the class III semaphorin receptor. Irregular CaP position frequently results in aberrant double exit points of motor axons, and secondary motor axons form aberrant exit points following CaP axons. Its expression pattern suggests that sema3ab regulates the CaP position. Indeed, irregular CaP positions and exit points are induced by Sema3ab knockdown, whose ectopic expression can alter the position of CaP cell bodies. Results suggest that Semaphorin-Neuropilin signaling plays an important role in position fine-tuning of CaP cell bodies to ensure proper exit points of motor axons.


Subject(s)
Body Patterning , Motor Neurons/metabolism , Spinal Cord/cytology , Spinal Cord/embryology , Zebrafish/embryology , Animals , Axons/metabolism , Embryo, Nonmammalian/cytology , Models, Biological , Motor Neurons/cytology , Nerve Growth Factors/metabolism , Neuropilin-1/metabolism , Organogenesis , Phenotype , RNA, Antisense/metabolism , Somites/cytology , Somites/embryology , Zebrafish Proteins/metabolism
13.
Development ; 133(5): 937-47, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16452100

ABSTRACT

In order for axons to reach their proper targets, both spatiotemporal regulation of guidance molecules and stepwise control of growth cone sensitivity to guidance molecules is required. Here, we show that, in zebrafish, Sema3a1, a secreted class 3 semaphorin, plays an essential role in guiding the caudal primary (CaP) motor axon that pioneers the initial region of the motor pathway. The expression pattern of Sema3a1 suggests that it delimits the pioneer CaP axons to the initial, common pathway via a repulsive action, but then CaP axons become insensitive to Sema3a1 beyond the common pathway. Indeed, nrp1a, which probably encodes a component of the Sema3a1 receptor, is specifically expressed by CaP during the early part of its outgrowth but not during later stages when extending into sema3a1-expressing muscle cells. To examine this hypothesis directly, expression of sema3a1 and/or nrp1a was manipulated in several ways. First, antisense knockdown of Sema3a1 induced CaP axons to branch excessively, stall and/or follow aberrant pathways. Furthermore, dynamic analysis showed they extended more lateral filopodia and often failed to pause at the horizontal myoseptal choice point. Second, antisense knockdown of Nrp1a and double knockdown of Nrp1a/Sema3a1 induced similar outgrowth defects in CaP. Third, CaP axons were inhibited by focally misexpressed sema3a1 along the initial common pathway but not along their pathway beyond the common pathway. Thus, as predicted, Sema3a1 is repulsive to CaP axons in the common region of the pathway, but not beyond the common pathway. Fourth, induced ubiquitous overexpression of sema3a1 caused the CaP axons but not the other primary motor axons to follow aberrant pathways. These results suggest that the repulsive response to Sema3a1 of the primary motor axons along the common pathway is both cell-type specific and dynamically regulated, perhaps via regulation of nrp1a.


Subject(s)
Axons/physiology , Growth Cones/physiology , Motor Neurons/cytology , Semaphorins/metabolism , Spinal Cord/embryology , Zebrafish Proteins/metabolism , Zebrafish/embryology , Animals , Axons/metabolism , Growth Cones/metabolism , Motor Neurons/metabolism , Nerve Growth Factors , Neuropilin-1/genetics , Neuropilin-1/metabolism , Semaphorins/genetics , Spinal Cord/cytology , Spinal Cord/metabolism , Zebrafish/genetics , Zebrafish/metabolism , Zebrafish Proteins/genetics
14.
Development ; 130(14): 3227-36, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12783793

ABSTRACT

Semaphorins are a large family of secreted and cell surface molecules that guide neural growth cones to their targets during development. Some semaphorins are expressed in cells and tissues beyond the nervous system suggesting the possibility that they function in the development of non-neural tissues as well. In the trunk of zebrafish embryos endothelial precursors (angioblasts) are located ventral and lateral to the somites. The angioblasts migrate medially and dorsally along the medial surface of the somites to form the dorsal aorta just ventral to the notochord. Here we show that in zebrafish Sema3a1 is involved in angioblast migration in vivo. Expression of sema3a1 in somites and neuropilin 1, which encodes for a component of the Sema3a receptor, in angioblasts suggested that Sema3a1 regulates the pathway of the dorsally migrating angioblasts. Antisense knockdown of Sema3a1 inhibited the formation of the dorsal aorta. Induced ubiquitous expression of sema3a1 in hsp70:(gfp)sema3a1(myc) transgenic embryos inhibited migration of angioblasts ventral and lateral to the somites and retarded development of the dorsal aorta, resulting in severely reduced blood circulation. Furthermore, analysis of cells that express angioblast markers following induced expression of sema3a1 or in a mutant that changes the expression of sema3a1 in the somites confirmed these results. These data implicate Sema3a1, a guidance factor for neural growth cones, in the development of the vascular system.


Subject(s)
Neovascularization, Physiologic , Semaphorin-3A/metabolism , Semaphorin-3A/physiology , Animals , Animals, Genetically Modified , Blotting, Western , Cell Movement , Green Fluorescent Proteins , In Situ Hybridization , Luminescent Proteins/metabolism , Mesoderm/pathology , Microscopy, Fluorescence , Models, Biological , Neuropilins/metabolism , Oligonucleotides, Antisense/metabolism , Zebrafish
SELECTION OF CITATIONS
SEARCH DETAIL
...